BackBrainsway Overview
Brainsway Ltd - ADR

Brainsway Target Price

See Brainsway's analyst price targets ($18) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.46

Average Target Price

$17.6030.8% upside

5 analysts in the last 4 months

High: $20 | Low: $14

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-31H.C. WainwrightRaghuram Selvaraju$1941.2% upsideOpen
2026-08-12BTIGSam Eiber$2048.6% upsideOpen
2026-07-20BTIG$1833.7% upsideOpen
2026-07-17H.C. WainwrightRaghuram Selvaraju$144% upsideOpen
2026-05-26H.C. WainwrightRaghuram Selvaraju$1726.3% upsideOpen
2026-01-26H.C. Wainwright$1511.4% upsideOpen
2026-01-22Northland Securities$1511.4% upsideOpen
2025-12-08H.C. WainwrightRaghuram Selvaraju$1210.8% downsideOpen
2024-08-07H.C. WainwrightRaghuram Selvaraju$840.6% downsideOpen
2024-05-09OppenheimerSteven Lichtman$5.559.1% downsideOpen
2024-05-09H.C. WainwrightRaghuram Selvaraju$7.544.3% downsideOpen
2022-11-17Northland Securities$2.581.4% downsideOpen
2022-08-22H.C. Wainwright$840.6% downsideOpen
2022-08-11Raymond James$470.3% downsideOpen

Brainsway (BWAY) FAQ

Brainsway (BWAY) currently reports a target price of $18. Use the charts on this page to explore Brainsway's target price history and peer comparisons.

Analysts' average 12-month price target for Brainsway is $18, about 30.8% upside from the current share price of $13.46. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $18, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Brainsway, and consider following BWAY for alerts when major investors trade the stock.

Brainsway is classified in the Healthcare sector. On target price, it currently shows $18. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BWAY with unrelated industries.